Bayer’s Nubeqa is approved by the US FDA as a treatment for metastatic castration-resistant prostate cancer (mCRPC) and ...

Experts are preparing a dialysis machine for use in critically ill patients in hospital intensive care units. Ardelyx and ...

The FDA’s rare disease innovation hub aims to streamline rare disease drug development. Credit: PeopleImages.com – Yuri A via ...

Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building ...

The UK MHRA has approved Pierre Fabre’s vibegron for the treatment of overactive bladder (OAB) syndrome in adult patients.

For the first half of 2024, Novartis reported net income of $5.9bn and net sales of $24.3bn. Credit: JHVEPhoto/Shutterstock.

The funding will aid CytoReason to expand disease models and proprietary data. Credit: PeopleImages.com – Yuri A / ...

The move grants Ligand royalty rights to QARZIBA (dinutuximab beta), a treatment for high-risk neuroblastoma in patients aged 12 months and above.